Influence of triflusal on platelet activation after coronary artery bypass graft

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 2, 2000, Pages 191-197

  Prieto, M A ^a   De La Cruz, J P ^b   Del Prado, M F ^a   Sanchez De La Cuesta F ^b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Cardiopulmonary bypass; Platelets; Thromboxane; Triflusal

Indexed keywords

ADENOSINE DIPHOSPHATE; BETA THROMBOGLOBULIN; COLLAGEN; THROMBOXANE B2; TRIFLUSAL;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION;

EID: 0034000670     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200003000-00011     Document Type: Article

References (27)

1. 1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med 1992; 326: 242-250.
2. 2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts). N Engl J Med 1992; 326: 310-318.
3. 3. Addonizio VP. Platelet function in cardiopulmonary bypass and artificial organs. Hematol Oncol Clin North Am 1990; 4: 145-155.
4. 4. Colman RW. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 1994; 49: 32-34.
5. 5. Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991; 75: 388-393.
6. 6. Zilla P, Fasol R, Groscurth P, Klepetko W, Reichenspurner H, Wolner E. Blood platelets in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 1989; 97: 379-388.
7. 7. Schussheim AE, Fuster V. Antithrombotic therapy and venous graft disease. Curr Opin Cardiol 1998; 13: 459-464.
8. 8. De La Cruz JP, Mata JM, Sánchez de la Cuesta F. Triflusal versus aspirin on the inhibition of human platelet and vascular cyclooxygenase. Gen Pharmacol 1992; 23: 297-300.
9. 9. De La Cruz JP, Pavía J, Bellido I, González MC, Sánchez de la Cuesta F. Platelet antiaggregatory effect of triflusal in human whole blood. Meth Find Exp Clin Pharmacol 1988; 10: 273-277.
10. 10. De La Cruz JP, Pavía J, Bellido I, González MC, Sánchez de la Cuesta F. Effect of triflusal and acetylsalicylic acid on platelet aggregation in human whole blood: influence of red blood cells and leukocytes. Meth Find Exp Clin Pharmacol 1988; 10: 363-367.
11. 11. De La Cruz JP, Pavía J, García Arnés J, Sánchez de la Cuesta F. Effects of triflusal and aspirin on platelet aggregation in whole blood and platelet-rich plasma of diabetic patients. Eur J Haematol 1988; 40: 232-236.
12. 12. De La Cruz JP, Villalobos MA, García P, Smith-Agreda JM, Sánchez de la Cuesta F. Effects of triflusal and its main metabolite HTB, on platelet interaction with subendothelium in healthy volunteers. Eur J Clin Pharmacol 1995; 47: 497-502.
13. 13. McNeely W, Goa KL. Triflusal. Drugs 1998; 55: 823-833.
14. 14. Cruz JM, Lopez V, Marfíl F, Pabón P, Navarro E, García-Dorado D, López-Bescós F. Managing acute myocardial infarction: clinical implications of the TIM study. Eur Heart J 1999; 1(suppl F): 12-18.
15. 15. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behaviour in blood. J Pharm Meth 1980; 3: 135-158.
16. 16. Dewar H, Marshall T, Weitgthman D, Prakash V, Boon P. Beta-thromboglobulin in antecubital vein blood. The influence of age, sex and blood group. Thromb Haemostas 1979; 42: 1159-1163.
17. 2. Clin Chem 1981; 27: 1417-1420.
18. 18. Boldt J, Zickman B, Czeke A, Herold C, Dapper F, Hempelmann G. Blood conservation techniques and platelet function in cardiac surgery. Anesthesiology 1991; 75: 805-812.
19. 19. Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991; 75: 388-393.
20. 20. Mohr R, Golan M, Martinowitz U, Rosner E, Goor DA, Ramot B. Effect of cardiac operation on platelets. J Thorac Cardiovasc Surg 1986; 92: 434-441.
21. 2 and ADP. Thromb Haemostas 1985; 54: 612-616.
22. 22. Edmunds LH, Ellison N, Colman RW, Niewiarowski S, Rao AK, Addonizio VP, et al. Platelet function during cardiac operation: comparison of membrane and bubble oxygenators. J Thorac Cardiovasc Surg 83: 805-812.
23. 23. Wenger RK, Lukasiewicz H, Mikuta BS, Niewiarowski S, Edmunds LH. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 97: 235-239.
24. 24. Valeri CR, Khabbaz K, Khuri S, Marquardt C, Ragno G, Feingold H, et al. Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg 1992; 104: 108-116.
25. 25. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79: 1201-1205.
26. 26. Gravlee GP, Rogers AT, Dudas LM, Taylor R, Roy RC, Case LD, et al. Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding. Anesthesiology 1992; 76: 393-401.
27. 27. Guiteras P, Altimira J, Aris A, Auge JM, Bassons T, Bonal J, et al. Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial. Eur Heart J 1989; 10: 159-167.